Smartkarma AI Primers, Smartkarma

αSK Primers

Smartkarma AI Primers

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

IKang Healthcare Group (ADR) / Equity Bottom-Up

<ul>
  <li>iKang Healthcare Group was a leading provider in China's rapidly growing private preventive healthcare market before its privatization and delisting from the NASDAQ in January 2019.</li>
  <li>The company was acquired by a consortium led by Yunfeng Capital and Alibaba Group for approximately $1.5 billion, following a prolonged and competitive bidding process that began in 2015.</li>
  <li>The take-private transaction occurred against a backdrop of intense domestic competition, primarily from rival Meinian Onehealth, which had also attempted to acquire iKang, leading to what iKang's management described as a hostile takeover attempt.</li>
</ul><p><em>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.</em></p>


  iKang Healthcare Group was a leading provider in China's rapidly growing private preventive healthcare market before its privatization and delisting from the NASDAQ in January 2019.
  The company was acquired by a consortium led by Yunfeng Capital and Alibaba Group for approximately $1.5 billion, following a prolonged and competitive bidding process that began in 2015.
  The take-private transaction occurred against a backdrop of intense domestic competition, primarily from rival Meinian Onehealth, which had also attempted to acquire iKang, leading to what iKang's management described as a hostile takeover attempt.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Primer: IKang Healthcare Group (ADR) (KANG US) - Aug 2026

China

iKang Healthcare Group, Inc is a corporate preventative healthcare provider. The Company provides medical examination, screening and other services. iKang focuses in mainland China.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Primer: IKang Healthcare Group (ADR) (KANG US) - Aug 2026

iKang Healthcare Group was a leading provider in China's rapidly growing private preventive healthcare market before its privatization and...

αSK Primers